Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Human subject protections

Executive Summary

FDA Commissioner Henney will be among witnesses testifying before a Government Reform/Criminal Justice, Drug Policy & Human Resources Subcommittee hearing on institutional review boards and federal protections for human research subjects May 3. Subcommittee Chairman Mica (R-Fla.) called the hearing in response to two Inspector General reports on IRBs (1"The Pink Sheet" April 17, p. 28). Also among the witnesses will be NIH Acting Director Ruth Kirschstein, MD, NIH Office of Protection from Research Risks Acting Director Gary Ellis, PhD and Deputy Inspector General George Grob

Latest Headlines
See All
UsernamePublicRestriction

Register

PS035962

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel